HHS released proposed regulations that would block Planned Parenthood and other abortion providers from receiving Title X family planning funds as well as ban any abortion referrals.
The U.S. Justice Department charged a former investigator for health insurer Anthem Blue Cross, a physician and three others for submitting false claims to insurers.
Four former University of Southern California students sued the school and a former campus gynecologist who they accuse of molesting patients over decades as a "serial sexual predator," according to a court filing Monday.
The justices ruled 5-4 that employers can prohibit their employees from turning to class-action litigation to resolve workplace disputes.
There's been a drop in the number of foreign-born medical graduates applying for residencies in the U.S. at the same time as the country struggles with physician staffing shortages. Industry stakeholders worry the decline comes from recent efforts to stem immigration.
On May 25, regulators will start enforcing the GDPR. Here's what every healthcare organization should know.
HHS plans to announce forthcoming regulations on Friday that would ban Title X family planning providers from referring patients to abortion clinics, and also prohibit funding for Planned Parenthood.
A federal appeals court approved a settlement between the House Republicans and the Trump administration, ending a lawsuit over cost-sharing reduction payments for the Obamacare exchanges.
California's physician aid-in-dying law was thrown into limbo when a state judge overturned it, ruling the Legislature unconstitutionally passed the law during a special session limited to healthcare issues.
HHS Secretary Alex Azar promised to use his "very powerful pen" to upend Medicare Part B's payment structure as his agency asked providers and pharmaceutical companies to weigh in on 340B changes.
As insurers begin to file 2019 rates, two trends are emerging: Rate hikes will be steep and vary widely across states and plans, as regulators use different strategies to stabilize individual markets and promote affordability and choice.
Congress' so-called upper chamber will be busy this week. Senate hearings are set for 340B, opioids and the 2019 budget.